Please log in for MITCNC member pricing
$30 MITCNC Members; $45 Non-Members
Join the club! Buy your membership HERE
There is an urgent need to take what we have learned in our new “genome era” and use it to create a new system of precision medicine, delivering the best therapeutic intervention at the right time, for the right patients.
Dr. Butte will highlight his lab’s recent work to build and apply tools that convert trillions of points of molecular, clinical, and epidemiological data -- “big data” -- into diagnostics, therapeutics, and new insights into disease. This includes finding new uses for drugs including new therapies for autoimmune diseases and cancer, discovering new druggable targets in disease, discovering new diagnostics, and how the next generation of biotech companies might even start in your garage.
Atul Butte, MD, PhD
- Priscilla Chan and Mark Zuckerberg Distinguished Professor
- Inaugural Director of the Institute for Computational Health Sciences (ichs.ucsf.edu) at UCSF
- Executive Director for Clinical Informatics across the six University of California Medical Schools and Medical Centers
Dr. Butte has authored over 200 publications with research repeatedly featured in the New York Times, Wall Street Journal, and Wired Magazine. He was elected into the National Academy of Medicine in 2015. In 2013 he was recognized by the Obama Administration as a White House Champion of Change in Open Science. Dr. Butte has founded three investor-backed data-driven companies: Personalis, Carmenta, and NuMedii.
Dr. Butte trained in Computer Science at Brown University, worked as a software engineer at Apple and Microsoft, received his MD at Brown University, trained in Pediatrics and Pediatric Endocrinology at Children's Hospital Boston, and then received his PhD from Harvard Medical School and MIT.
Date and Time
Thursday, May 24, 2018
6:00 PM - 9:00 PM PT
1500 Seaport Blvd, Redwood City, CA View Map